The Board of Directors in
The capital increase is expected to be registered within 7 days, and following the issuance of the new shares, the issued share capital of
-End-
Contacts
CEO,
ir@bergenbio.com
CFO,
rune.skeie@bergenbio.com
Forward looking statements
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
http://publish.ne.cision.com//Release/ViewReleaseHtml/5B02EFF5BD9B3F41E0C856B0705FC7D6
https://mb.cision.com/Main/15728/3424886/1475656.pdf
(c) 2021 Cision. All rights reserved., source